Deisenhofen, Germany

Klaus Fuchs

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Fuchs. Retrieved from https://idiyas.com/inventor/klaus-fuchs-a6455b7r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus Fuchs - Innovator in Hepatitis C Research

Introduction

Klaus Fuchs is a notable inventor based in Deisenhofen, Germany. He has made significant contributions to the field of medical diagnostics, particularly in relation to the hepatitis C virus. His work has been instrumental in advancing the understanding and testing of this virus.

Latest Patents

Klaus Fuchs holds a patent for "Polypeptides derived from proteins of the hepatitis C virus, test kits." This innovation is crucial for the development of effective diagnostic tools for hepatitis C, which affects millions worldwide. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Fuchs is currently employed at Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His role at Roche has allowed him to work on cutting-edge technologies that enhance the accuracy and efficiency of hepatitis C testing.

Collaborations

Throughout his career, Klaus Fuchs has collaborated with esteemed colleagues such as Manfred Motz and Michael Roggendorf. These partnerships have fostered innovation and have contributed to the advancement of diagnostic methods in the medical field.

Conclusion

Klaus Fuchs is a prominent figure in the realm of hepatitis C research and diagnostics. His contributions through patents and collaborations have significantly impacted the medical community. His work continues to pave the way for advancements in the diagnosis and treatment of hepatitis C.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…